Medically Reviewed By
Dr. Aditya Singh, MBBS, MD (Pharmacology)
Reg No: MCI-654321 • Verified Medical Reviewer
Degarelix Accord
(degarelix)
Uses, side effects, dosage information & price range
About this medicine
Degarelix Accord is a gonadotrophin releasing hormone (GnRH) antagonist indicated: for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.
Common Brand Names for this Composition
The following popular commercial brand names contain degarelix as their active ingredient composition:
Degapride 80mg Injection
Sun Pharmaceutical Industries Ltd
Degatide 120 Injection
Cipla Ltd
Degarelix Accord
Accord Healthcare S.L.U.
Firmagon
Ferring Pharmaceuticals A/S
Common Substitutes & Alternatives
These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.
Key Information
Salt / Composition
degarelix
Category
Other hormone antagonists and related agents
Manufacturer
Accord Healthcare S.L.U.
Medical Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.
Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.